Pre-implant n-terminal pro-B-type natriuretic peptide predicts mortality and morbidity following cardiac resynchronization therapy

Paul William Foley, Kayvan Khadjooi, Shajil Chalil, Russell E. A. Smith, Selvakumar Ramachandran, Michael Frenneaux, Francisco Leyva

Research output: Contribution to journalAbstract

Original languageEnglish
Pages (from-to)A356-357
Number of pages2
JournalJournal of the American College of Cardiology
Volume51
Issue number10 Suppl. A
Publication statusPublished - 11 Mar 2008

Cite this

Foley, P. W., Khadjooi, K., Chalil, S., Smith, R. E. A., Ramachandran, S., Frenneaux, M., & Leyva, F. (2008). Pre-implant n-terminal pro-B-type natriuretic peptide predicts mortality and morbidity following cardiac resynchronization therapy. Journal of the American College of Cardiology, 51(10 Suppl. A), A356-357.